Core A Biology and Antibody Core

核心 A 生物学和抗体核心

• 批准号: 7898774
• 负责人: Loren Gi Fong
• 金额: $ 47.24万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7898774
• 关键词: Address; Air; Antibodies; Biology; Biomedical Research; Complex; Core Facility; Diabetes Mellitus; Faculty; Gene Targeting; Human Resources; Inherited; Institution; Laboratories; Left; Monoclonal Antibodies; Mus; Obesity; Pain; Plasma; Positioning Attribute; Postdoctoral Fellow; Process; Production; Program Research Project Grants; Proteins; Reagent; Research; Research Project Grants; Role; Technical Expertise; Techniques; Time; Triglyceride Metabolism; experience; lipid biosynthesis; lipid metabolism; mouse model; polyclonal antibody; tool

Overview The production of genetically-modified mouse models and antibody reagents has revolutionized biomedical research (1-4). These research tools have made it possible to answer many questions that cannot be addressed otherwise, and have helped to define the roles of specific gene products in complex processes such as adipogenesis and obesity, diabetes mellitus, and plasma lipid metabolism. The principal objectives of the Mouse Model and Antibody Core of this Program Project Grant (PPG) are to generate gene-targeted mice and to prepare both monoclonal and polyclonal antibodies for the three projects. Genetically modified mouse models and polyclonal or monoclonal antibodies will be used in all three projects. It is both expensive and time consuming to generate new lines of mice and to create antibodies, and both require considerable technical expertise. Even though mouse and antibody reagents are critical for many modern biomedical research projects, it is very difficult for the majority of laboratories to keep the requisite techniques "up in the air" at all times. Often, the required technical expertise disappears when a technician leaves for another institution or a postdoctoral fellow departs for a faculty position. It is then inefficient, expensive, and painful to re-establish the techniques within the laboratory. Therefore, it makes sense, particularly for a PPG, to centralize these functions within a core facility. In this PPG, we are fortunate to inherit the technical expertise of BayGenomics personnel (Drs. Fong, Young, Reue, Hu) in creating genetargeted mice, and the substantial experience of Drs. Bensadoun, Fong, and Young in the production of monoclonal and polyclonal antibodies.

概述 转基因小鼠模型和抗体试剂的生产彻底改变了生物医学 研究（1-4）。这些研究工具使人们有可能回答许多无法回答的问题。 另外，还帮助确定了特定基因产物在复杂过程中的作用， 如脂肪形成和肥胖、糖尿病和血浆脂质代谢。 本项目资助（PPG）的小鼠模型和抗体核心的主要目标是 产生基因靶向小鼠，并为这三个项目制备单克隆和多克隆抗体。 这三个项目都将使用转基因小鼠模型和多克隆或单克隆抗体。 产生新的小鼠品系和产生抗体既昂贵又耗时， 需要相当的技术专长。尽管小鼠和抗体试剂对许多人来说至关重要， 现代生物医学研究项目，大多数实验室很难保持必要的 技术“在空中”在任何时候。通常情况下，当技术人员 离开到另一个机构或博士后研究员离开教师职位。这样效率就低了， 在实验室内重新建立技术是昂贵的，并且是痛苦的。因此，这是有道理的， 特别是对于PPG，将这些功能集中在核心设施内。在这个PPG，我们很幸运， 继承BayGenomics人员（Fong，Young，Reue，Hu博士）的技术专长， Bensadoun，Fong和Young博士在生产 单克隆和多克隆抗体。